New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy
Objective. To assess the efficacy of biologic drugs, beyond tumor necrosis factor- (TNF-) α inhibitors, in the management of noninfectious refractory scleritis, either idiopathic or associated with systemic immune-mediated disorders. Patients and Methods. This is a retrospective study assessing the...
Saved in:
Main Authors: | Claudia Fabiani, Jurgen Sota, Maite Sainz-de-la-Maza, Laura Pelegrín, Giacomo Emmi, Giuseppe Lopalco, Florenzo Iannone, Lorenzo Vannozzi, Silvana Guerriero, Maria Chiara Gelmi, Donato Rigante, Gian Marco Tosi, José Hernández-Rodríguez, Luca Cantarini |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2020/8294560 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Update on the Medical Management of Gastrointestinal Behçet’s Disease
by: Giuseppe Lopalco, et al.
Published: (2017-01-01) -
Interleukin-1 as a Common Denominator from Autoinflammatory to Autoimmune Disorders: Premises, Perils, and Perspectives
by: Giuseppe Lopalco, et al.
Published: (2015-01-01) -
Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still’s Disease
by: Antonio Vitale, et al.
Published: (2020-01-01) -
IgG4-Related Disease Presenting as Isolated Scleritis
by: Eran Berkowitz, et al.
Published: (2017-01-01) -
Infectious scleritis: a review of etiologies, clinical features, and management strategies
by: Supriya Sharma, et al.
Published: (2025-02-01)